A Study of Significances of Serum CCK-18,miR-122 and HMGA2 Expression in HBV-ACLF Patients and Related Analysis of Prognostic Factors

A Study of Significances of Serum CCK-18,miR-122 and HMGA2 Expression in HBV-ACLF Patients and Related Analysis of Prognostic Factors

GUO Hongyan, WANG Rui, LIU Qingfeng

PDF(1473 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1473 KB)

Labeled Immunoassays and Clinical Medicine ›› 2023, Vol. 30 ›› Issue (6) : 907-913. DOI: 10.11748/bjmy.issn.1006-1703.2023.06.002

Original Article

A Study of Significances of Serum CCK-18,miR-122 and HMGA2 Expression in HBV-ACLF Patients and Related Analysis of Prognostic Factors

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 30(6): 907-913 https://doi.org/10.11748/bjmy.issn.1006-1703.2023.06.002

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1473 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉